ES2055280T3 - Sistema monocapa para la administracion transdermica de farmacos. - Google Patents
Sistema monocapa para la administracion transdermica de farmacos.Info
- Publication number
- ES2055280T3 ES2055280T3 ES90123100T ES90123100T ES2055280T3 ES 2055280 T3 ES2055280 T3 ES 2055280T3 ES 90123100 T ES90123100 T ES 90123100T ES 90123100 T ES90123100 T ES 90123100T ES 2055280 T3 ES2055280 T3 ES 2055280T3
- Authority
- ES
- Spain
- Prior art keywords
- patch
- pharmaces
- layer system
- transdermic administration
- transdermic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
UN PARCHE MONOCAPA PARA APLICACION TRANSDERMICA DE MEDICAMENTOS FARMACEUTICOS. EL PARCHE ESTA CARACTERIZADO POR TENER UNA SOLA MASA DE ELASTOMERO EN LA CUAL ESTAN HOMOGENEAMENTE DISPERSADOS EL MEDICAMENTO ACTIVO Y UN INTENSIFICADOR DE ABSORCION PERCUTANEA. EL PARCHE ES PARTICULARMENTE INDICADO PARA SUMINISTRAR ABULTEROL MEDICINA AGONISTA ADRENERGICA BETA2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42576689A | 1989-12-04 | 1989-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2055280T3 true ES2055280T3 (es) | 1994-08-16 |
Family
ID=23687946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90123100T Expired - Lifetime ES2055280T3 (es) | 1989-12-04 | 1990-12-03 | Sistema monocapa para la administracion transdermica de farmacos. |
Country Status (11)
Country | Link |
---|---|
US (2) | US5164189A (es) |
EP (1) | EP0431519B1 (es) |
JP (1) | JPH07133230A (es) |
KR (1) | KR910011247A (es) |
AT (1) | ATE107176T1 (es) |
CA (1) | CA2031376A1 (es) |
DE (1) | DE69009946T2 (es) |
DK (1) | DK0431519T3 (es) |
ES (1) | ES2055280T3 (es) |
IE (1) | IE66203B1 (es) |
PT (1) | PT96059B (es) |
Families Citing this family (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679399A (en) | 1987-07-17 | 1997-10-21 | Bio Barrier, Inc. | Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers |
US5549924A (en) * | 1987-07-17 | 1996-08-27 | Robin Renee Thill Shlenker | Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer |
JPH01153633A (ja) * | 1987-12-10 | 1989-06-15 | Kyorin Pharmaceut Co Ltd | 経皮吸収製剤 |
US5633009A (en) * | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
US20050152950A1 (en) * | 1995-11-13 | 2005-07-14 | Saffran Bruce N. | Method and apparatus for macromolecular delivery using a coated membrane |
AU2247997A (en) * | 1996-01-29 | 1997-08-20 | Savor, Evelyn P. | Method of treating undesired uterine contractions using optically pure R-or RR-isomers of adrenergic beta-2 agonists |
US5708036A (en) * | 1996-01-29 | 1998-01-13 | Pesterfield, Jr.; E. Charles | Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
US6248789B1 (en) | 1996-08-29 | 2001-06-19 | Stuart L. Weg | Administration of ketamine to manage pain and to reduce drug dependency |
GB9719076D0 (en) * | 1997-09-09 | 1997-11-12 | Movevirgo Limited | A material for producing a medical dressing and a medical dressing produced using the material |
CN100357143C (zh) * | 1998-01-20 | 2007-12-26 | 易通公司 | 起步发动机扭矩限制 |
US5900249A (en) * | 1998-02-09 | 1999-05-04 | Smith; David J. | Multicomponent pain relief topical medication |
SE9803240D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
KR100369779B1 (ko) * | 1999-07-12 | 2003-01-29 | 주식회사 엘지생명과학 | 교감신경 흥분성 기관지확장 약물의 경피흡수 투여용 조성물및 이를 포함하는 경피흡수 투여용 제형 |
US7713546B1 (en) * | 2001-04-03 | 2010-05-11 | Soft Gel Technologies, Inc. | Corosolic acid formulation and its application for weight-loss management and blood sugar balance |
US20070218087A1 (en) * | 2001-12-07 | 2007-09-20 | Norbert Hoenzelaer | Method of controlled release of vanillin for nasal and/or pulmonary uptake |
DE10200578A1 (de) * | 2002-01-09 | 2003-07-10 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
AU2003252075A1 (en) * | 2002-07-16 | 2004-02-02 | University Of South Florida | Human immunosuppressive protein |
EP2130541A3 (en) | 2002-07-29 | 2013-12-18 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
US7241456B2 (en) * | 2002-10-25 | 2007-07-10 | Australian Importers Ltd. | Formulations for topical delivery of bioactive substances and methods for their use |
NZ540282A (en) | 2002-11-18 | 2008-06-30 | Yaupon Therapeutics Inc | Analgesic uses of norketamine and ketamine/norketamine prodrugs |
WO2004075075A1 (en) * | 2003-01-21 | 2004-09-02 | Alza Corporation | A computational model for transdermal drug delivery |
US20060246104A1 (en) * | 2003-04-16 | 2006-11-02 | Massia Stephen P | Stable rgd peptidomimetic composition |
ES2365223T3 (es) | 2003-08-07 | 2011-09-26 | Rigel Pharmaceuticals, Inc. | Compuestos 2,4-pirimidindiamínicos y usos como agentes antiproliferativos. |
US20050186269A1 (en) * | 2004-02-25 | 2005-08-25 | Udell Ronald G. | Stabilized feverfew formulations |
US8168600B2 (en) * | 2004-04-23 | 2012-05-01 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
US20060051435A1 (en) * | 2004-08-19 | 2006-03-09 | Udell Ronald G | Nutritional supplement for body fat reduction |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
US20070104805A1 (en) * | 2005-11-01 | 2007-05-10 | Udell Ronald G | Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives |
AT502717A1 (de) * | 2005-11-09 | 2007-05-15 | Omnica Gmbh | Pharmazeutische verwendung einer verbindung |
GB0523031D0 (en) * | 2005-11-11 | 2005-12-21 | Yaupon Therapeutics | Enhancement of morphine analgesia by s(-)-norketamine |
WO2007098507A2 (en) | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
WO2007100870A2 (en) * | 2006-02-28 | 2007-09-07 | The Trustees Of Columbia University In The City Of New York | Methods for compact aggregation of dermal cells |
AT503329A1 (de) * | 2006-03-02 | 2007-09-15 | Omnica Gmbh | Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält |
AT503521A1 (de) * | 2006-05-05 | 2007-11-15 | Omnica Gmbh | Verwendung eines extraktes von kiwi-frucht |
US8278358B2 (en) * | 2006-07-06 | 2012-10-02 | Omnica Gmbh | Lipoic acid derivatives |
JP2008044926A (ja) * | 2006-08-14 | 2008-02-28 | Trustees Of Columbia Univ In The City Of New York | Wnt信号伝達に関係した分泌タンパク質 |
ATE497496T1 (de) | 2006-10-19 | 2011-02-15 | Rigel Pharmaceuticals Inc | 2,4-pyridimediamon-derivate als hemmer von jak- kinasen zur behandlung von autoimmunerkrankungen |
EP2420505A1 (en) | 2006-11-21 | 2012-02-22 | Rigel Pharmaceuticals, Inc. | Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses |
US7820207B2 (en) | 2007-03-15 | 2010-10-26 | Omnica Gmbh | Stabilized anthocyanin compositions |
US8623429B2 (en) | 2007-03-15 | 2014-01-07 | Omnica Gmbh | Stabilized anthocyanin compositions |
CA2587805C (en) * | 2007-04-25 | 2014-02-18 | The Procter & Gamble Company | Improved vitamin d content uniformity in pharmaceutical dosage forms |
US20080293644A1 (en) * | 2007-04-27 | 2008-11-27 | Thomas Eidenberger | Guava extract |
US8034983B2 (en) * | 2007-06-06 | 2011-10-11 | Multi-Tech Specialty Chemicals, Co., Ltd. | Process for the preparation of xanthophyll crystals |
US20110015158A1 (en) | 2007-12-11 | 2011-01-20 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
WO2009089380A2 (en) * | 2008-01-08 | 2009-07-16 | The Trustees Of Columbia University In The City Of New York | Methods for p2ry5 mediated regulation of hair growth and mutants thereof |
WO2009131958A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising triazine derivatives |
US20090270398A1 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Pyridazine Derivatives |
US8207205B2 (en) * | 2008-04-21 | 2012-06-26 | Institute For Oneworld Health | Compounds, compositions and methods comprising oxadiazole derivatives |
WO2009131951A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
PT2367812E (pt) | 2008-08-22 | 2016-01-20 | Sanofi Sa | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoxi-etil)-4-trifluorometoxi-1h-indol-3-il]metanona como um inibidor da triptase de mastócitos |
JP2012503005A (ja) * | 2008-09-19 | 2012-02-02 | インスティテュート フォア ワンワールド ヘルス | イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。 |
AR074776A1 (es) | 2008-12-18 | 2011-02-09 | Sanofi Aventis | Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente |
ES2624622T3 (es) | 2008-12-30 | 2017-07-17 | Rigel Pharmaceuticals, Inc. | Inhibidores de pirimidindiamina cinasa |
PL2389372T3 (pl) | 2009-01-23 | 2016-02-29 | Rigel Pharmaceuticals Inc | Kompozycje i sposoby hamowania szlaku JAK |
CN104523661A (zh) | 2009-02-06 | 2015-04-22 | 南加利福尼亚大学 | 含有单萜的治疗组合物 |
US8511216B2 (en) * | 2009-03-30 | 2013-08-20 | Kanzaki Kokyukoki Mfg. Co., Ltd. | Hydraulic actuator unit |
US8343976B2 (en) * | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
RU2561729C2 (ru) | 2009-07-08 | 2015-09-10 | Дермира (Канада), Инк. | Аналоги tofa, применимые при лечении дерматологических расстройств или состояний |
US20110034415A1 (en) | 2009-07-20 | 2011-02-10 | Thomas Eidenberger | Walnut extracts for nutraceutical applications |
FR2955324A1 (fr) | 2010-01-15 | 2011-07-22 | Sanofi Aventis | [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones disubstituees |
EP2493468A1 (en) | 2009-10-30 | 2012-09-05 | Sanofi | Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders |
US20110144200A1 (en) | 2009-12-14 | 2011-06-16 | Thomas Eidenberger | Combination of carotenoids and epi-lutein |
MX2012006739A (es) | 2009-12-23 | 2012-06-28 | Sanofi Sa | Profarmacos de [4 [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il] -(1h-pirrolo-piridin-il)-metanonas y sintesis de estos. |
WO2011078984A1 (en) | 2009-12-23 | 2011-06-30 | Sanofi | [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof |
WO2011130716A2 (en) | 2010-04-16 | 2011-10-20 | Access Pharmaceuticals, Inc. | A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers |
US20110288103A1 (en) | 2010-04-20 | 2011-11-24 | Institute For Oneworld Health | Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives |
CN103068390A (zh) | 2010-04-20 | 2013-04-24 | 寰宇一家健康研究所 | 包含哒嗪磺酰胺衍生物的化合物、组合物和方法 |
PL2563771T3 (pl) | 2010-04-24 | 2016-06-30 | Viamet Pharmaceuticals Nc Inc | Związki inhibitora metaloenzymu |
CN103201280B (zh) | 2010-07-28 | 2016-08-10 | 里格尔药品股份有限公司 | 抑制jak途径的组合物和方法 |
US8968755B2 (en) | 2010-10-23 | 2015-03-03 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
US8685381B2 (en) | 2010-10-23 | 2014-04-01 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
EP2632903A4 (en) | 2010-10-28 | 2014-11-26 | Viamet Pharmaceuticals Inc | METALLOENZYMHEMMERVERBINDUNGEN |
DK2635299T3 (da) | 2010-11-02 | 2019-10-21 | Univ Columbia | Fremgangsmåder til behandling af hårtabsforstyrrelser |
EA024197B1 (ru) | 2010-11-13 | 2016-08-31 | Иннокрин Фармасьютикалс, Инк. | Соединения, ингибирующие металлоферменты |
EA201390876A1 (ru) | 2010-12-13 | 2013-12-30 | Вайамет Фармасьютикалс, Инк. | Соединения, ингибирующие металлоферменты |
CA2828360A1 (en) | 2011-02-25 | 2012-08-30 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Chrysophaentin analogs that inhibit ftsz protein |
CN103501821A (zh) | 2011-03-08 | 2014-01-08 | 艾克塞斯制药公司 | 用于递送活性剂穿过生物膜的靶向纳米载体*** |
US8809378B2 (en) | 2011-06-19 | 2014-08-19 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
CA2839691A1 (en) | 2011-06-19 | 2012-12-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
US8883797B2 (en) | 2011-06-23 | 2014-11-11 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
WO2013019169A1 (en) | 2011-08-01 | 2013-02-07 | Institute For Oneworld Health | Phosphate prodrugs |
JP2014531425A (ja) | 2011-09-02 | 2014-11-27 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 肥満の代謝異常を治療するためのCaMKII、IP3R、カルシニューリン、p38、およびMK2/3阻害剤 |
EP2788343B1 (en) | 2011-12-11 | 2018-02-28 | Viamet Pharmaceuticals (NC), Inc. | Metalloenzyme inhibitor compounds |
IN2014DN06792A (es) | 2012-01-20 | 2015-05-22 | Viamet Pharmaceuticals Inc | |
NZ629898A (en) | 2012-03-23 | 2016-04-29 | Oxigene Inc | Compositions and methods for inhibition of cathepsins |
DK2830662T3 (da) | 2012-03-29 | 2019-01-02 | Univ Columbia | Fremgangsmåder til behandlng af hårtabsforstyrrelser |
WO2013173506A2 (en) | 2012-05-16 | 2013-11-21 | Rigel Pharmaceuticals, Inc. | Method of treating muscular degradation |
ES2661911T3 (es) * | 2012-07-16 | 2018-04-04 | Grünenthal GmbH | Parche farmacéutico para la administración transdérmica de tapentadol |
WO2014013014A1 (en) | 2012-07-18 | 2014-01-23 | Fundació Privada Centre De Regulació Genòmica (Crg) | Jak inhibitors for activation of epidermal stem cell populations |
JP2016506930A (ja) | 2013-01-25 | 2016-03-07 | ライジェル ファーマシューティカルズ, インコーポレイテッド | 炎症性腸疾患を処置するための化合物および方法 |
JP2016515508A (ja) | 2013-03-15 | 2016-05-30 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | 融合タンパク質及びその方法 |
CA2941357A1 (en) | 2014-03-07 | 2015-09-11 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Non-narcotic crmp2 peptides targeting sodium channels for chronic pain |
CA2942231A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
EP3237452A4 (en) | 2014-12-23 | 2018-12-05 | The Trustees of Columbia University in the City of New York | Fusion proteins and methods thereof |
ES2926063T3 (es) | 2015-03-19 | 2022-10-21 | Mycovia Pharmaceuticals Inc | Compuestos antifúngicos y procedimientos de fabricación |
DK3331879T3 (da) | 2015-08-04 | 2020-08-10 | Rigel Pharmaceuticals Inc | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne |
EP3349587B1 (en) | 2015-09-18 | 2020-07-22 | NQP 1598, Ltd. | Antifungal compound process |
US10188750B1 (en) | 2015-10-23 | 2019-01-29 | University Of South Florida | Self-replicating cell selective gene delivery compositions, methods, and uses thereof |
MX2018008105A (es) | 2015-12-30 | 2018-11-12 | Vps 3 Inc | Compuestos inhibidores de metaloenzima. |
ES2940911T3 (es) | 2016-06-27 | 2023-05-12 | Rigel Pharmaceuticals Inc | Compuestos de 2,4-diamino-pirimidina y su uso como inhibidores de IRAK4 |
EP3478091B1 (en) | 2016-06-29 | 2024-03-20 | Halo Life Science, LLC | Method of preparing a low odor dicholinium ellagate salt and other low odor organic salts of choline |
EP3532470B1 (en) | 2016-10-26 | 2022-12-07 | Rigel Pharmaceuticals, Inc. | Oxazole derivatives for use as irak inhibitors and method for their preparation |
WO2018081294A1 (en) | 2016-10-26 | 2018-05-03 | Rigel Pharmaceuticals, Inc. | Pyrazole amide compounds as irak inhibitors |
FI3562487T3 (fi) | 2016-12-29 | 2023-12-14 | Ji Xing Pharmaceuticals Hong Kong Ltd | Metalloentsyymi-inhibiittoriyhdisteitä |
WO2018125799A2 (en) | 2016-12-29 | 2018-07-05 | Viamet Pharmaceuticals (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
US10590121B2 (en) | 2017-06-29 | 2020-03-17 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and methods for making and using |
US20210292410A1 (en) | 2017-12-07 | 2021-09-23 | Morphosys Ag | Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment |
HUE063896T2 (hu) | 2018-05-03 | 2024-02-28 | Rigel Pharmaceuticals Inc | RIP1 inhibitorvegyületek, valamint ezek elõállítása és alkalmazása |
ES2947446T3 (es) | 2018-05-03 | 2023-08-09 | Rigel Pharmaceuticals Inc | Compuestos inhibidores de RIP1 y métodos para fabricar y usar los mismos |
US20220000880A1 (en) | 2018-11-01 | 2022-01-06 | Rigel Pharmaceuticals, Inc. | Method and composition embodiments for treating acute myeloid leukemia |
US20200377518A1 (en) | 2019-05-29 | 2020-12-03 | Rigel Pharmaceuticals, Inc. | Method of preventing and treating thrombosis |
WO2021026451A1 (en) | 2019-08-08 | 2021-02-11 | Rigel Pharmaceuticals, Inc. | Compounds and method for treating cytokine release syndrome |
CA3147444A1 (en) | 2019-08-14 | 2021-02-18 | Rigel Pharmaceuticals, Inc. | Method of blocking or ameliorating cytokine release syndrome |
MX2022002292A (es) | 2019-08-30 | 2022-06-02 | Rigel Pharmaceuticals Inc | Compuestos de pirazol, formulaciones de los mismos y un metodo para usar los compuestos y/o formulaciones. |
EP4025568A1 (en) | 2019-09-06 | 2022-07-13 | Rigel Pharmaceuticals, Inc. | Rip1 inhibitory compounds and methods for making and using the same |
CR20220075A (es) | 2019-09-06 | 2022-07-14 | Rigel Pharmaceuticals Inc | Compuestos inhibidores de rip1 y métodos para prepararlos y usarlos |
KR20220079919A (ko) | 2019-11-07 | 2022-06-14 | 리겔 파마슈티칼스, 인크. | 헤테로시클릭 rip1 억제 화합물 |
US20220288047A1 (en) | 2021-03-03 | 2022-09-15 | Rigel Pharmaceuticals, Inc. | Method for treating a disease or condition using a pyrazole compound or formulation thereof |
TW202300490A (zh) | 2021-03-11 | 2023-01-01 | 美商雷傑製藥公司 | 雜環rip1激酶抑制劑 |
US20230303555A1 (en) | 2022-03-23 | 2023-09-28 | Rigel Pharmaceuticals, Inc. | Pyrimid-2-yl-pyrazole compounds as irak inhibitors |
WO2023192479A1 (en) | 2022-03-31 | 2023-10-05 | Rigel Pharmaceuticals, Inc. | Tricyclic irak inhibitors |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US4136219A (en) * | 1973-02-09 | 1979-01-23 | Odam Norman E | Method of applying polyurethane paint to vulcanized rubber |
US3935329A (en) * | 1973-05-09 | 1976-01-27 | Sheller-Globe Corporation | Method of manufacturing new paintable rubber products |
US4562075A (en) * | 1982-05-20 | 1985-12-31 | Nelson Research & Development Co. | Penetration enhancers for transdermal drug delivery of systemic agents |
DE2751328A1 (de) * | 1976-12-21 | 1978-06-29 | Gen Electric | Durch ultraschall verbindbare polyphenylenaether-zusammensetzungen |
JPS55139449A (en) * | 1979-04-18 | 1980-10-31 | Mitsubishi Gas Chem Co Inc | Resin composition |
DE3010374A1 (de) * | 1980-03-18 | 1981-10-08 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von copolymerisaten von styrol und/oder dessen derivaten |
JPS5812304B2 (ja) * | 1980-09-16 | 1983-03-07 | 旭化成株式会社 | 芳香族ポリエ−テル樹脂組成物 |
DE3102253A1 (de) * | 1981-01-24 | 1982-09-02 | Basf Ag, 6700 Ludwigshafen | Thermoplastische formmasse |
WO1983003834A1 (en) * | 1981-02-26 | 1983-11-10 | General Electric Company | Polyphenylene ether compositions and process |
US4513120A (en) * | 1981-03-23 | 1985-04-23 | General Electric Company | Polyphenylene ether compositions |
JPS57174344A (en) * | 1981-04-21 | 1982-10-27 | Mitsubishi Gas Chem Co Inc | Impact-resistant polyphenylene ether resin composition |
US4360618A (en) * | 1981-11-19 | 1982-11-23 | Monsanto Company | Low acrylonitrile content styrene-acrylonitrile polymers blended with polyphenylene oxide |
US4435180A (en) * | 1982-05-25 | 1984-03-06 | Alza Corporation | Elastomeric active agent delivery system and method of use |
FR2542998B1 (fr) * | 1983-03-24 | 1986-01-31 | Rhone Poulenc Sante | Nouvelle forme transdermale du dinitrate d'isosorbide |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
JPS59204650A (ja) * | 1983-05-10 | 1984-11-20 | Japan Synthetic Rubber Co Ltd | 熱可塑性樹脂組成物 |
KR860001431B1 (ko) * | 1983-07-01 | 1986-09-24 | 닛뽕 고오세이 고무 가부시기 가이샤 | 열가소성 수지 조성물 |
NL8303497A (nl) * | 1983-10-12 | 1985-05-01 | Gen Electric | Voorwerp geheel of gedeeltelijk vervaardigd uit een polymeermengsel en voorzien van een polyurethaanlaklaag of een polyurethaanlijmlaag. |
US4578423A (en) * | 1983-12-12 | 1986-03-25 | Monsanto Company | Polyblends of polyphenylene oxide and styrene-acrylonitrile polymers having broad acrylonitrile compositional distribution |
US4933184A (en) * | 1983-12-22 | 1990-06-12 | American Home Products Corp. (Del) | Menthol enhancement of transdermal drug delivery |
DE3347278A1 (de) * | 1983-12-28 | 1985-07-11 | Bayer Ag, 5090 Leverkusen | Wirkstoffabgabesysteme |
DE3347277A1 (de) * | 1983-12-28 | 1985-07-11 | Bayer Ag, 5090 Leverkusen | Wirkstoffabgabesysteme |
EP0150021A3 (en) * | 1984-01-20 | 1987-07-15 | General Electric Company | Polyphenylene ether resin compositions having improved melt flow and paintability |
US4605670A (en) * | 1984-02-01 | 1986-08-12 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering metoclopramide |
DE3409079A1 (de) * | 1984-03-13 | 1985-09-19 | Bayer Ag, 5090 Leverkusen | Medizinische pflaster |
CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
EP0177329B1 (en) * | 1984-10-05 | 1992-09-30 | Hercon Laboratories Corporation | Device for transdermal drug administration |
US4678516A (en) * | 1984-10-09 | 1987-07-07 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
US4638043A (en) * | 1984-11-13 | 1987-01-20 | Thermedics, Inc. | Drug release system |
DE3586713T2 (de) * | 1984-11-15 | 1993-05-13 | Hercon Lab | Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen. |
ATE77962T1 (de) * | 1985-02-25 | 1992-07-15 | Univ Rutgers | Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen. |
US4699777A (en) * | 1985-08-21 | 1987-10-13 | Schering Corporation | Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea |
CA1288698C (en) * | 1985-08-30 | 1991-09-10 | Yie W. Chien | Transdermal anti-anginal pharmaceutical dosage |
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
JPH0747535B2 (ja) * | 1985-11-26 | 1995-05-24 | 日東電工株式会社 | 消炎鎮痛用貼付剤 |
JPS6310716A (ja) * | 1986-07-02 | 1988-01-18 | Teijin Ltd | β−刺激薬外用剤 |
ZA875317B (en) * | 1986-08-01 | 1988-01-25 | Warner-Lambert Company | Transdermal compositions |
US4906169A (en) * | 1986-12-29 | 1990-03-06 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
US4814173A (en) * | 1987-09-08 | 1989-03-21 | Warner-Lambert Company | Silicone elastomer transdermal matrix system |
US4820525A (en) * | 1987-09-17 | 1989-04-11 | American Home Products Corporation (Del.) | Transdermal drug delivery system |
US4942037A (en) * | 1988-06-02 | 1990-07-17 | Merck & Co., Inc. | Transdermal delivery systems |
-
1990
- 1990-12-03 DE DE69009946T patent/DE69009946T2/de not_active Expired - Fee Related
- 1990-12-03 DK DK90123100.1T patent/DK0431519T3/da active
- 1990-12-03 IE IE434590A patent/IE66203B1/en not_active IP Right Cessation
- 1990-12-03 CA CA002031376A patent/CA2031376A1/en not_active Abandoned
- 1990-12-03 PT PT96059A patent/PT96059B/pt not_active IP Right Cessation
- 1990-12-03 ES ES90123100T patent/ES2055280T3/es not_active Expired - Lifetime
- 1990-12-03 EP EP90123100A patent/EP0431519B1/en not_active Expired - Lifetime
- 1990-12-03 AT AT90123100T patent/ATE107176T1/de not_active IP Right Cessation
- 1990-12-04 JP JP2419319A patent/JPH07133230A/ja active Pending
- 1990-12-04 KR KR1019900019842A patent/KR910011247A/ko not_active Application Discontinuation
-
1991
- 1991-03-11 US US07/667,992 patent/US5164189A/en not_active Expired - Lifetime
-
1992
- 1992-04-10 US US07/866,617 patent/US5290561A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69009946T2 (de) | 1994-11-03 |
KR910011247A (ko) | 1991-08-07 |
EP0431519A1 (en) | 1991-06-12 |
CA2031376A1 (en) | 1991-06-05 |
IE66203B1 (en) | 1995-12-13 |
DE69009946D1 (de) | 1994-07-21 |
PT96059B (pt) | 1998-07-31 |
JPH07133230A (ja) | 1995-05-23 |
PT96059A (pt) | 1991-09-30 |
US5164189A (en) | 1992-11-17 |
ATE107176T1 (de) | 1994-07-15 |
IE904345A1 (en) | 1991-06-05 |
US5290561A (en) | 1994-03-01 |
DK0431519T3 (da) | 1994-07-04 |
EP0431519B1 (en) | 1994-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2055280T3 (es) | Sistema monocapa para la administracion transdermica de farmacos. | |
DE3685895D1 (de) | Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen. | |
ES2171469T3 (es) | Composicion administrada por via nasal y preparacion que la contiene. | |
DK0460020T3 (da) | Medikamentleveringssammensætninger | |
ES2155073T3 (es) | Matriz de dos fases para un dispositivo de aporte de farmacos de liberacion sostenida. | |
ES2162927T3 (es) | Formulacion para la aplicacion por inhalacion. | |
BR9206631A (pt) | Sistema de maior penetração na pele para melhor administração tópica de medicamentos | |
ATE173162T1 (de) | Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen | |
PT901368E (pt) | Promotores da penetracao dermica e sistemas de administracao de farmacos compreendendo os mesmos. | |
MY102378A (en) | Transdermal delivery system. | |
BR9909192A (pt) | Preparações galênicas de meloxicam para administração oral | |
FI905718A0 (fi) | Transdermalt medel. | |
PT93191A (pt) | Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas | |
KR910011244A (ko) | 로젠지제 | |
BR0012082A (pt) | Formulação farmacêutica para administração compreendendo morfina e seu uso | |
DE3587698D1 (de) | Pharmazeutische Präparate. | |
ITMI921831A1 (it) | Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive | |
ATE69724T1 (de) | Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs. | |
PT93430A (pt) | Processo para a preparacao de um sistema terapeutico transdermico para a para a aministracao de substancias activas em fases e sua utilizacao para a administracao local ou sistemica de substancias activas | |
FR2356425A1 (fr) | Application a titre de medicaments de derives organiques de la montmorillonite | |
ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
ITMI911950A0 (it) | Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante | |
KR960003718A (ko) | 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 | |
BR9808876A (pt) | Sistema de liberação de medicamento | |
Tsizin et al. | The structure and anthelmintic action of tricyclic analogs of praziquantel and 4-acylpiperazinones-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 431519 Country of ref document: ES |